![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 07, 2022 7:03:49 PM
IMO, after reverse splits, additional share raises, lots of talk about benchmarks, redesign, rebranding, and other promises, the stock price continues to trade at its lows.
Even the thoughts of a buyout from Medtronics HASN'T MOVED THE STOCK PRICE UP.
Every year-end, tax loss selling drags the price down to low levels.
Talks of a buy out at 2-6 billion have not materialized during my watching period.
MY BOTTOM LINE TAKE: There is little if any hope for this stock to climb back to any respectible levels.
IF YOU REALLY THINK THIS STOCK HAS POTENTIAL, I would sell now, wait 30- days and buy it back and then forget about the stock for several years. Look at it as a total loss and if it does succeed, be glad and take the gain.
JMO
We all have a right to post our opinions, whether you agree with them or not.
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM